This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Fundacio Privada Institut D'inbestigacio Biomedica De Bell Vitge, Fundacio Privada Institute De Recerca Biomedica De Barcelona, Fundacio Privada Parc Cientific De Barcelona. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 2 
Years Active: 2014
Title: Sara Preciado Gallego: Innovator in Cancer Treatment
Introduction
Sara Preciado Gallego is a prominent inventor based in L'Hospitalet de Llobregat, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of new compounds. Her work focuses on creating effective therapies that can inhibit tumor cell proliferation.
Latest Patents
Sara holds a patent for "Fluorinated thiazoles for use in treating cancer." This patent describes compounds that can inhibit cell proliferation of tumor cells independently of the p53 protein. The compounds include various radicals and are designed to induce apoptosis in several tumor cells, making them useful for treating multiple types of cancer.
Career Highlights
Throughout her career, Sara has worked with esteemed institutions such as the Universitat de Barcelona and the Fundació Privada Institut d'Investigació Biomèdica de Bellvitge. Her research has been pivotal in advancing the understanding of cancer therapies and developing new treatment options.
Collaborations
Sara has collaborated with notable colleagues, including Joan Gil Santano and Rodolfo Lavilla Grifols. These partnerships have enhanced her research efforts and contributed to the success of her innovative projects.
Conclusion
Sara Preciado Gallego is a trailblazer in the field of cancer treatment, with her patented innovations paving the way for new therapeutic options. Her dedication to research and collaboration continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile